
Ypsomed Holding Investor Relations Material
Latest events

H2 24/25
Ypsomed Holding
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ypsomed Holding AG
Access all reports
Ypsomed Holding AG is a Switzerland-based medical device company that specializes in the design, development, and manufacture of injection and infusion systems for self-medication. It provides a wide range of products, including autoinjectors, dual chamber pens, and pen injectors, catering to various medical conditions such as diabetes, infertility, and growth disorders. Ypsomed also offers comprehensive services from design and development to manufacturing and assembly, supporting pharmaceutical and biotechnology companies throughout the product lifecycle. Ypsomed's headquarters are located in Burgdorf, Switzerland, and its shares are listed on the SWX.
Key slides for Ypsomed Holding AG


H2 24/25
Ypsomed Holding AG


H2 24/25
Ypsomed Holding AG
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
YPSN
Country
🇨🇭 Switzerland